Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment – a retrospective, German-Swiss multicenter real-world data analysis

Date Published

April 1, 2025

Heidenreich S, Egger-Heidrich K, Halter JP, Jost L, Stolzel F, Perl M, Denk A, Edinger M, Herr W, Kroger N, Wolff D, Ayuk F, Fante MA. Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment – a retrospective, German-Swiss multicenter real-world data analysis. Bone Marrow Transplant. 2025 Apr. 60:439-446. doi:10.1038/s41409-024-02507-9. PMID: 39809902